Birmingham Capital Management Co. Inc. AL lowered its position in shares of Clorox Company (The) (NYSE:CLX) by 0.1% during the second quarter, Holdings Channel reports. The firm owned 30,639 shares of the company’s stock after selling 45 shares during the period. Clorox Company (The) accounts for 1.6% of Birmingham Capital Management Co. Inc. AL’s investment portfolio, making the stock its 24th largest position. Birmingham Capital Management Co. Inc. AL’s holdings in Clorox Company (The) were worth $4,082,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in CLX. Jacobi Capital Management LLC boosted its position in shares of Clorox Company (The) by 0.3% in the first quarter. Jacobi Capital Management LLC now owns 1,282 shares of the company’s stock worth $172,000 after buying an additional 4 shares during the period. Bridgeworth LLC boosted its position in shares of Clorox Company (The) by 0.3% in the first quarter. Bridgeworth LLC now owns 1,869 shares of the company’s stock worth $252,000 after buying an additional 5 shares during the period. Valley National Advisers Inc. boosted its position in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock worth $116,000 after buying an additional 5 shares during the period. Blue Chip Partners Inc. boosted its position in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock worth $122,000 after buying an additional 6 shares during the period. Finally, Wade G W & Inc. boosted its position in shares of Clorox Company (The) by 0.3% in the first quarter. Wade G W & Inc. now owns 3,173 shares of the company’s stock worth $428,000 after buying an additional 8 shares during the period. Institutional investors own 70.29% of the company’s stock.

Clorox Company (NYSE:CLX) opened at 133.94 on Friday. Clorox Company has a 52 week low of $111.24 and a 52 week high of $141.76. The stock has a market cap of $17.29 billion, a PE ratio of 25.11 and a beta of 0.40. The stock has a 50 day moving average price of $133.72 and a 200 day moving average price of $133.47.

Clorox Company (The) (NYSE:CLX) last issued its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. During the same quarter in the prior year, the business earned $1.30 earnings per share. The company’s revenue was up 2.9% compared to the same quarter last year. On average, equities analysts predict that Clorox Company will post $5.68 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Clorox Company (The) (NYSE:CLX) Shares Sold by Birmingham Capital Management Co. Inc. AL” was first reported by Daily Political and is the property of of Daily Political. If you are viewing this news story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/08/11/clorox-company-the-nyseclx-shares-sold-by-birmingham-capital-management-co-inc-al.html.

A number of equities analysts recently commented on the company. UBS Group AG restated a “sell” rating and set a $121.00 target price (up from $117.00) on shares of Clorox Company (The) in a report on Friday, May 5th. Jefferies Group LLC restated a “hold” rating and set a $137.00 target price (up from $136.00) on shares of Clorox Company (The) in a report on Wednesday. Royal Bank Of Canada set a $115.00 target price on Clorox Company (The) and gave the company a “hold” rating in a report on Monday, April 24th. Vetr cut Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 target price for the company. in a report on Tuesday, April 18th. Finally, BidaskClub upgraded Clorox Company (The) from a “strong sell” rating to a “sell” rating in a report on Monday, July 31st. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company’s stock. Clorox Company (The) presently has an average rating of “Hold” and an average target price of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.